Global Acute Ischemic Stroke Diagnosis Market
According to the report “Acute Ischemic Stroke Diagnosis Market“published by Market Data Forecast, the
global market is projected to reach USD 2.508 billion by 2020, at a CAGR of 6.7% from 2015 to 2020.
For full report refer to http://www.marketdataforecast.com/market-reports/global-acute-ischemicstroke-diagnosis-market-265/
Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood
supply to the brain. Rising prevalence of acute ischemia stroke cases are driving the global demand for
surgical procedures in acute stroke treatment
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/globalacute-ischemic-stroke-diagnosis-market-265/request-sample
Technological advancements in surgical procedures along with rising aging population, increased demand
for minimally invasive procedures and growth in healthcare spending are the other major factors driving
the growth of Global Acute Ischemic Stroke diagnosis and treatment market on the other side excessive
usage of medication for the treatment of ischemic stroke and high cost of surgical procedures are
hindering the growth of the market.
Global Acute Ischemic Stroke Diagnosis and Treatment Market is segmented into Diagnostic type and
Surgery type
1) Diagnostic type
Computed Tomography
Ultrasound
Magnetic Resonance Imaging
Cerebral angiography and
Nuclear imaging
2) Surgery Type
Carotid Endarterectomy
Angioplasty
Endovascular Mechanical Thrombectomy
3) Geography
North America
Europe
Asia-Pacific
Latin America
Africa & Middle-East
Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips
Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation
(Concentric Medical, Inc.) and Hitachi, Ltd.
+1 888-702-9626 | www.marketdataforecast.com | [email protected]